애보트, 바클레이즈 비중확대 신규 커버리지…목표가 120달러

원본 출처: https://247wallst.com/investing/2026/10/07/here-are-wednesdays-top-wall-street-analyst-research-calls-abbot-laboratories-appfolio-delek-us-holdings-flutter-entertainment-honeywell-aerospace-intuitive-surgical-marvell-netapp/

Barclays initiated Abbott Laboratories (NYSE: ABT) at Overweight with a $120 target.